Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: A retrospective study of single institution

Table 2 Analyses of treatment-related variables associated with recurrence/progression in MOGCTs

Variables	No. Patients (%)	Recurrence No (Rate, %)	P value
Treatment modalities
Surgery only	8(14.0)	1(1.8)	0.4342
Surgery + chemotherapy	49(86.0)	5(8.8)
Operation methods
Fertility sparing	42(73.7)	1(1.8)	0.0006
Cystectomy without staging op.	1(1.8)	0(0.0)
USO without staging op.	20(35.1)	0(0.0)
USO with staging op.	21(36.8)	1(1.8)
Non-fertility sparing	15(26.3)	5(8.8)
Hysterectomy + BSO without staging op.	5(8.8)	0(0.0)
Hysterectomy + BSO with staging op.	10(17.5)	5(8.8)
Chemotherapy regimens (n = 49)
BEP	9(18.4)	1(2.0)	0.9008
EP	28(57.1)	3(6.1)
VBP	2(4.1)	0(0.0)
Others	10(20.4)	10(20.4)
Residual lesions
None	47(82.5)	1(1.8)	< 0.0001
≤ 1 cm	8(14.0)	3(5.3)
> 1 cm	2(3.5)	2(3.5)

USO, unilateral salpingo-oophorectomy; BSO, bilateral salpingo-oophorectomy; BEP, bleomycin, etoposide, and cisplatin; EP, etoposide and cisplatin; VBP, vinblastine, bleomycin, and cisplatin.

ISSN: 1477-7819